These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 6939874

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Trial of penicillamine in advanced primary biliary cirrhosis.
    Dickson ER, Fleming TR, Wiesner RH, Baldus WP, Fleming CR, Ludwig J, McCall JT.
    N Engl J Med; 1985 Apr 18; 312(16):1011-5. PubMed ID: 3885033
    [Abstract] [Full Text] [Related]

  • 3. Effect of D-penicillamine on copper retention in patients with primary billiary cirrhosis.
    Deering TB, Dickson ER, Fleming CR, Geall MG, McCall JT, Baggenstoss AH.
    Gastroenterology; 1977 Jun 18; 72(6):1208-12. PubMed ID: 870369
    [Abstract] [Full Text] [Related]

  • 4. A prospective trial of D-penicillamine in primary biliary cirrhosis.
    Matloff DS, Alpert E, Resnick RH, Kaplan MM.
    N Engl J Med; 1982 Feb 11; 306(6):319-26. PubMed ID: 7033789
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Primary biliary cirrhosis: critical evaluation and treatment policies.
    Sherlock S.
    Scand J Gastroenterol Suppl; 1982 Feb 11; 77():63-74. PubMed ID: 6750830
    [Abstract] [Full Text] [Related]

  • 10. Lichen planus-like lesions caused by penicillamine in primary biliary cirrhosis.
    Seehafer JR, Rogers RS, Fleming CR, Dickson ER.
    Arch Dermatol; 1981 Mar 11; 117(3):140-2. PubMed ID: 6452095
    [Abstract] [Full Text] [Related]

  • 11. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, Michieletti P, Minuk GY, Pappas SC, Scully LJ.
    Hepatology; 1994 May 11; 19(5):1149-56. PubMed ID: 8175136
    [Abstract] [Full Text] [Related]

  • 12. Autoimmune associations in primary biliary cirrhosis.
    Culp KS, Fleming CR, Duffy J, Baldus WP, Dickson ER.
    Mayo Clin Proc; 1982 Jun 11; 57(6):365-70. PubMed ID: 6896227
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F, Akarca US, Ersöz G, Karasu Z, Yüce G, Batur Y.
    Hepatogastroenterology; 2002 Jun 11; 49(47):1195-200. PubMed ID: 12239904
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immune complexes and the treatment of biliary cirrhosis.
    Epstein O, Thomas H.
    N Engl J Med; 1979 Jun 28; 300(26):1487-8. PubMed ID: 449894
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. D-Penicillamine-induced Goodpasture's-like syndrome in primary biliary cirrhosis--successful treatment with plasmapheresis and immunosuppressives.
    Matloff DS, Kaplan MM.
    Gastroenterology; 1980 May 28; 78(5 Pt 1):1046-9. PubMed ID: 7380177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.